Pharma Ophthalmic Market

List of Tables
Table 1. Pharma Ophthalmic CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pharma Ophthalmic Market Trends
Table 3. Pharma Ophthalmic Market Drivers
Table 4. Pharma Ophthalmic Market Challenges
Table 5. Pharma Ophthalmic Market Restraints
Table 6. Global Pharma Ophthalmic Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pharma Ophthalmic Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pharma Ophthalmic Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pharma Ophthalmic Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pharma Ophthalmic Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pharma Ophthalmic Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pharma Ophthalmic Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pharma Ophthalmic Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Pharma Ophthalmic Sales Share by Manufacturer, 2017-2022
Table 15. Global Pharma Ophthalmic Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Pharma Ophthalmic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pharma Ophthalmic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Ophthalmic as of 2021)
Table 18. Top Players of Pharma Ophthalmic in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pharma Ophthalmic Product Type
Table 20. Date of International Manufacturers Enter into Pharma Ophthalmic Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pharma Ophthalmic Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pharma Ophthalmic Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pharma Ophthalmic Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pharma Ophthalmic Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Pharma Ophthalmic Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pharma Ophthalmic Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pharma Ophthalmic Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Pharma Ophthalmic Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Pharma Ophthalmic Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pharma Ophthalmic Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pharma Ophthalmic Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Pharma Ophthalmic Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pharma Ophthalmic Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Pharma Ophthalmic Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pharma Ophthalmic Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Pharma Ophthalmic Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pharma Ophthalmic Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Pharma Ophthalmic Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pharma Ophthalmic Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Pharma Ophthalmic Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Novartis Pharma Ophthalmic Product
Table 46. Novartis Recent Development
Table 47. Allergan Corporation Information
Table 48. Allergan Description and Business Overview
Table 49. Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Allergan Product
Table 51. Allergan Recent Development
Table 52. Roche Corporation Information
Table 53. Roche Description and Business Overview
Table 54. Roche Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Roche Product
Table 56. Roche Recent Development
Table 57. Valeant Corporation Information
Table 58. Valeant Description and Business Overview
Table 59. Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Valeant Product
Table 61. Valeant Recent Development
Table 62. Regeneron Corporation Information
Table 63. Regeneron Description and Business Overview
Table 64. Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Regeneron Product
Table 66. Regeneron Recent Development
Table 67. Santen Corporation Information
Table 68. Santen Description and Business Overview
Table 69. Santen Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Santen Product
Table 71. Santen Recent Development
Table 72. Bayer Corporation Information
Table 73. Bayer Description and Business Overview
Table 74. Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Bayer Product
Table 76. Bayer Recent Development
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Business Overview
Table 79. Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. Senju Corporation Information
Table 83. Senju Description and Business Overview
Table 84. Senju Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Senju Product
Table 86. Senju Recent Development
Table 87. Akorn Corporation Information
Table 88. Akorn Description and Business Overview
Table 89. Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Akorn Product
Table 91. Akorn Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Pharma Ophthalmic Customers List
Table 95. Pharma Ophthalmic Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Ophthalmic Product Picture
Figure 2. Global Pharma Ophthalmic Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pharma Ophthalmic Market Size 2017-2028 (US$ Million)
Figure 4. Global Pharma Ophthalmic Sales 2017-2028 (K Pcs)
Figure 5. United States Pharma Ophthalmic Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pharma Ophthalmic Market Size 2017-2028 (US$ Million)
Figure 7. United States Pharma Ophthalmic Sales 2017-2028 (K Pcs)
Figure 8. United States Pharma Ophthalmic Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pharma Ophthalmic Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Pharma Ophthalmic Report Years Considered
Figure 11. Product Picture of Retinal disorders drugs
Figure 12. Product Picture of Allergic, inflammatory and infective drugs
Figure 13. Product Picture of Glaucoma drugs
Figure 14. Product Picture of Dry eye drugs
Figure 15. Product Picture of Other ophthalmic drugs
Figure 16. Global Pharma Ophthalmic Market Share by Type in 2022 & 2028
Figure 17. Global Pharma Ophthalmic Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Pharma Ophthalmic Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Pharma Ophthalmic Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Pharma Ophthalmic Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Pharma Ophthalmic Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Pharma Ophthalmic Market Share by Type in 2022 & 2028
Figure 23. United States Pharma Ophthalmic Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Pharma Ophthalmic Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Pharma Ophthalmic Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Pharma Ophthalmic Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Pharma Ophthalmic Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Glaucoma
Figure 29. Product Picture of Dry eye syndrome
Figure 30. Product Picture of Retinal diseases
Figure 31. Product Picture of Other ophthalmic indications
Figure 32. Global Pharma Ophthalmic Market Share by Application in 2022 & 2028
Figure 33. Global Pharma Ophthalmic Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Pharma Ophthalmic Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Pharma Ophthalmic Sales by Application (2017-2028) & (K Pcs)
Figure 36. Global Pharma Ophthalmic Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Pharma Ophthalmic Price by Application (2017-2028) & (USD/Pcs)
Figure 38. United States Pharma Ophthalmic Market Share by Application in 2022 & 2028
Figure 39. United States Pharma Ophthalmic Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Pharma Ophthalmic Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Pharma Ophthalmic Sales by Application (2017-2028) & (K Pcs)
Figure 42. United States Pharma Ophthalmic Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Pharma Ophthalmic Price by Application (2017-2028) & (USD/Pcs)
Figure 44. North America Pharma Ophthalmic Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. North America Pharma Ophthalmic Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Pharma Ophthalmic Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 49. Europe Pharma Ophthalmic Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Pharma Ophthalmic Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 56. Asia-Pacific Pharma Ophthalmic Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Pharma Ophthalmic Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 68. Latin America Pharma Ophthalmic Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Pharma Ophthalmic Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 73. Middle East & Africa Pharma Ophthalmic Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. U.A.E Pharma Ophthalmic Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Pharma Ophthalmic Value Chain
Figure 78. Pharma Ophthalmic Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed